Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Abarelix: a promising new treatment option for patients with prostate cancer

June 12, 1998

More on Ilex Oncology's chemopreventive agent

June 11, 1998

Duke University pioneers novel therapy for GBM

June 11, 1998

Vapreotide, RC-3940-II and cetrorelix: novel peptide analogues for treating renal cell carcinoma

June 11, 1998

Miravant and Xillix Technologies enter early-stage cancer collaboration

June 10, 1998

GlycoDesign starts phase II trial of GD0039 for the treatment of RCC

June 10, 1998

Clinical trial results for DUROS leuprolide implant announced at AUA meeting

June 10, 1998

No-approval recommendation given for AD-32 by FDA advisory committee

June 9, 1998

Antitumor, antifungal cryptophycins developed by U.S. pharmaceutical/academic team

June 9, 1998

BMS prepares novel sulfenamide taxane derivatives

June 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...